BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 23108395)

  • 21. The PIAS-like Coactivator Zmiz1 Is a Direct and Selective Cofactor of Notch1 in T Cell Development and Leukemia.
    Pinnell N; Yan R; Cho HJ; Keeley T; Murai MJ; Liu Y; Alarcon AS; Qin J; Wang Q; Kuick R; Elenitoba-Johnson KS; Maillard I; Samuelson LC; Cierpicki T; Chiang MY
    Immunity; 2015 Nov; 43(5):870-83. PubMed ID: 26522984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of deregulated genes of Notch signaling pathway in human T cell acute lymphoblastic leukemia cell lines and clinical samples.
    Paryan M; Mohammadi-Yeganeh S; Samiee SM; Soleimani M; Arefian E; Azadmanesh K; Poopak B; Mostafavi E; Karimipoor M; Mahdian R
    Mol Biol Rep; 2013 Oct; 40(10):5531-40. PubMed ID: 23982259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling.
    Pear WS; Aster JC
    Curr Opin Hematol; 2004 Nov; 11(6):426-33. PubMed ID: 15548998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Notch1 receptor regulates AKT protein activation loop (Thr308) dephosphorylation through modulation of the PP2A phosphatase in phosphatase and tensin homolog (PTEN)-null T-cell acute lymphoblastic leukemia cells.
    Hales EC; Orr SM; Larson Gedman A; Taub JW; Matherly LH
    J Biol Chem; 2013 Aug; 288(31):22836-48. PubMed ID: 23788636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stabilization of Notch1 by the Hsp90 Chaperone Is Crucial for T-Cell Leukemogenesis.
    Wang Z; Hu Y; Xiao D; Wang J; Liu C; Xu Y; Shi X; Jiang P; Huang L; Li P; Liu H; Qing G
    Clin Cancer Res; 2017 Jul; 23(14):3834-3846. PubMed ID: 28143869
    [No Abstract]   [Full Text] [Related]  

  • 26. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.
    Tatarek J; Cullion K; Ashworth T; Gerstein R; Aster JC; Kelliher MA
    Blood; 2011 Aug; 118(6):1579-90. PubMed ID: 21670468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CARMA1 is required for Notch1-induced NF-κB activation in SIL-TAL1-negative T cell acute lymphoblastic leukemia.
    Zhang N; Xu J; Wang R; Pan T; Zhang H; Yin L; Yao Y; Xu L; Zhu S; Wu Q; Li Z; Liu X; Xu K; Niu M
    J Mol Med (Berl); 2021 Oct; 99(10):1447-1458. PubMed ID: 34223928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ARRB1-Promoted NOTCH1 Degradation Is Suppressed by OncomiR miR-223 in T-cell Acute Lymphoblastic Leukemia.
    Shu Y; Wang Y; Lv WQ; Peng DY; Li J; Zhang H; Jiang GJ; Yang BJ; Liu S; Zhang J; Chen YH; Tang S; Wan KX; Yuan JT; Guo W; Fu G; Qi XK; Liu ZD; Liu HY; Yang C; Zhang LH; Liu FJ; Yu J; Zhang PH; Qu B; Zhao H; He TC; Zou L
    Cancer Res; 2020 Mar; 80(5):988-998. PubMed ID: 31822496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling.
    Medyouf H; Gusscott S; Wang H; Tseng JC; Wai C; Nemirovsky O; Trumpp A; Pflumio F; Carboni J; Gottardis M; Pollak M; Kung AL; Aster JC; Holzenberger M; Weng AP
    J Exp Med; 2011 Aug; 208(9):1809-22. PubMed ID: 21807868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity.
    Armstrong F; Brunet de la Grange P; Gerby B; Rouyez MC; Calvo J; Fontenay M; Boissel N; Dombret H; Baruchel A; Landman-Parker J; Roméo PH; Ballerini P; Pflumio F
    Blood; 2009 Feb; 113(8):1730-40. PubMed ID: 18984862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Constitutive Notch pathway activation in murine ZMYM2-FGFR1-induced T-cell lymphomas associated with atypical myeloproliferative disease.
    Ren M; Cowell JK
    Blood; 2011 Jun; 117(25):6837-47. PubMed ID: 21527531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 Modulates Notch Signaling in MCF-7 Breast Cancer Cells by Associating With the Notch Transcriptional Complex Via MAML1.
    Yun J; Espinoza I; Pannuti A; Romero D; Martinez L; Caskey M; Stanculescu A; Bocchetta M; Rizzo P; Band V; Band H; Kim HM; Park SK; Kang KW; Avantaggiati ML; Gomez CR; Golde T; Osborne B; Miele L
    J Cell Physiol; 2015 Dec; 230(12):3115-27. PubMed ID: 26033683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notch-mediated repression of miR-223 contributes to IGF1R regulation in T-ALL.
    Gusscott S; Kuchenbauer F; Humphries RK; Weng AP
    Leuk Res; 2012 Jul; 36(7):905-11. PubMed ID: 22424712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress.
    Melnick AF; Mullin C; Lin K; McCarter AC; Liang S; Liu YE; Wang Q; Jerome NA; Choe E; Kunnath N; Bodanapu G; Akter F; Magnuson B; Kumar S; Lombard DB; Muntean AG; Ljungman M; Sekiguchi J; Ryan RJH; Chiang MY
    Blood; 2023 Dec; 142(25):2159-2174. PubMed ID: 37616559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NOTCH1-RBPJ complexes drive target gene expression through dynamic interactions with superenhancers.
    Wang H; Zang C; Taing L; Arnett KL; Wong YJ; Pear WS; Blacklow SC; Liu XS; Aster JC
    Proc Natl Acad Sci U S A; 2014 Jan; 111(2):705-10. PubMed ID: 24374627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia.
    González-García S; Mosquera M; Fuentes P; Palumbo T; Escudero A; Pérez-Martínez A; Ramírez M; Corcoran AE; Toribio ML
    Blood; 2019 Dec; 134(24):2171-2182. PubMed ID: 31530562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts.
    Agnusdei V; Minuzzo S; Frasson C; Grassi A; Axelrod F; Satyal S; Gurney A; Hoey T; Seganfreddo E; Basso G; Valtorta S; Moresco RM; Amadori A; Indraccolo S
    Leukemia; 2014 Feb; 28(2):278-88. PubMed ID: 23774673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL.
    Jeannet R; Mastio J; Macias-Garcia A; Oravecz A; Ashworth T; Geimer Le Lay AS; Jost B; Le Gras S; Ghysdael J; Gridley T; Honjo T; Radtke F; Aster JC; Chan S; Kastner P
    Blood; 2010 Dec; 116(25):5443-54. PubMed ID: 20829372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia.
    Mirandola L; Chiriva-Internati M; Montagna D; Locatelli F; Zecca M; Ranzani M; Basile A; Locati M; Cobos E; Kast WM; Asselta R; Paraboschi EM; Comi P; Chiaramonte R
    J Pathol; 2012 Apr; 226(5):713-22. PubMed ID: 21984373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss.
    Medyouf H; Gao X; Armstrong F; Gusscott S; Liu Q; Gedman AL; Matherly LH; Schultz KR; Pflumio F; You MJ; Weng AP
    Blood; 2010 Feb; 115(6):1175-84. PubMed ID: 20008304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.